Department of Otorhinolaryngology, University Hospital Ulm, Frauensteige 12, 89075 Ulm, Germany.
Int J Mol Sci. 2020 Dec 29;22(1):247. doi: 10.3390/ijms22010247.
For the development and evaluation of new head and neck squamous cell carcinoma (HNSCC) therapeutics, suitable, well-characterized animal models are needed. Thus, by analyzing orthotopic versus subcutaneous models of HNSCC in immunocompetent mice, we evaluated the existence of adenosine-related immunosuppressive B- and T lymphocyte populations within the tumor microenvironment (TME). Applying the SCC VII model for the induction of HNSCC in immunocompetent C3H/HeN mice, the cellular TME was characterized after tumor initiation over time by flow cytometry. The TME in orthotopic grown tumors revealed a larger population of tumor-infiltrating lymphocytes (TIL) with more B cells and CD4 T cells than the subcutaneously grown tumors. Immune cell populations in the blood and bone marrow showed a rather distinct reaction toward tumor induction and tumor location compared to the spleen, lymph nodes, or thymus. In addition, large numbers of immunosuppressive B- and T cells were identified within the TME but also in secondary lymphoid organs, independently of the tumor initiation site. The altered immunogenic TME may influence the response to any treatment attempt. Moreover, when analyzing the TME and other lymphoid organs of tumor-bearing mice, we observed conditions reflecting largely those of patients suffering from HNSCC suggesting the C3H/HeN mouse model as a suitable tool for studies aiming to target immunosuppression to improve anti-cancer therapies.
为了开发和评估新的头颈部鳞状细胞癌(HNSCC)治疗方法,需要合适的、特征明确的动物模型。因此,通过分析免疫功能正常的小鼠中 HNSCC 的原位和皮下模型,我们评估了肿瘤微环境(TME)中存在的与腺苷相关的免疫抑制 B 和 T 淋巴细胞群。我们应用 SCCVII 模型在免疫功能正常的 C3H/HeN 小鼠中诱导 HNSCC,然后通过流式细胞术随时间推移分析肿瘤起始后的 TME 中的细胞。与皮下生长的肿瘤相比,原位生长的肿瘤中的肿瘤浸润淋巴细胞(TIL)具有更大的 B 细胞和 CD4 T 细胞群体。与脾脏、淋巴结或胸腺相比,血液和骨髓中的免疫细胞群体对肿瘤诱导和肿瘤位置的反应更为明显。此外,在 TME 中也在次级淋巴器官中发现了大量的免疫抑制 B 和 T 细胞,而与肿瘤起始部位无关。改变的免疫原性 TME 可能会影响对任何治疗尝试的反应。此外,当分析荷瘤小鼠的 TME 和其他淋巴器官时,我们观察到的条件反映了很大程度上那些患有 HNSCC 的患者的情况,这表明 C3H/HeN 小鼠模型是一种用于靶向免疫抑制以改善抗癌治疗的研究的合适工具。